Cargando…
TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy
Since the discovery of RNA interference (RNAi), RNAi technology has rapidly developed into an efficient tool for post-transcriptional gene silencing, which has been widely used for clinical or preclinical treatment of various diseases including cancer. Small interfering RNA (siRNA) is the effector m...
Autores principales: | Cao, Shuwen, Lin, Chunhao, Li, Xiuling, Liang, Yixia, Saw, Phei Er |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407678/ https://www.ncbi.nlm.nih.gov/pubmed/34475756 http://dx.doi.org/10.2147/IJN.S322901 |
Ejemplares similares
-
Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy
por: Saw, Phei Er, et al.
Publicado: (2018) -
Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy
por: Lee, Jinju, et al.
Publicado: (2016) -
Transforming Tea Catechins into Potent Anticancer Compound: Analysis of Three Boronated-PEG Delivery System
por: Guo, Mingyan, et al.
Publicado: (2021) -
TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy
por: Luo, Yuanli, et al.
Publicado: (2020) -
Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy
por: Huang, Zixian, et al.
Publicado: (2022)